Literatur
-
1
Bridges C B, Winquist A G, Fukuda K. et al .
Advisory Committee on Immunization Practies: Prevention and control of influenza.
MMWR Recomm Rep.
2000;
49
1-38
-
2
Beyer W E, de Bruijn I A, Palache A M. et al .
Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies.
Arch Intern Med.
1999;
159 (2)
182-188
-
3
Demicheli V, Rivetti D, Deeks J J. et al .
Vaccines for preventing influenza in healthy adults.
Cochrane Database Syst Rev.
2001;
(4)
CD001269
-
4
Gross P A, Quinnan Jr G V, Weksler M E. et al .
Immunization of elderly people with high doses of influenza vaccine.
J Am Geriatr Soc.
1988;
36 (3)
209-212
-
5
STIKO .
Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand.
Epidemiol Bull.
2004;
30
235-250
-
6
Bernstein E, Kaye D, Abrutyn E. et al .
Immune response to influenza vaccination in a large healthy elderly population.
Vaccine.
1999;
17 (1)
82-94
-
7
Nichol K.
Improving influenza vaccination rates for high-risk inpatients.
Am J Med.
1991;
91
584-588
-
8
Nichol K L, Margolis K L, Wouremna J. et al .
Effectiveness of influenza vaccine in the elderly.
Gerontology.
1996;
42 (5)
274-279
-
9
Nichol K L, Margolis K L, Wuorenma J. et al .
The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.
N Engl J Med.
1994;
331 (12)
778-784
-
10
Nichol K L.
Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza.
Arch Intern Med.
2001;
161 (5)
749-759
-
11
Govaert T M, Sprenger M J, Dinant G J. et al .
Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial.
Vaccine.
1994;
12 (13)
1185-1189
-
12
Gross P A, Hermogenes A W, Sacks H S. et al .
The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.
Ann Intern Med.
1995;
123 (7)
518-527
-
13
Nichol K L, Baken L, Nelson A.
Relation between influenza vaccination and outpatients visits, hospitalization, and mortality in elderly persons with chronic lung disease.
Ann Intern Med.
1999;
130 (5)
397-403
-
14
Laver G, Garman E.
Pandemic influenza: its origin and control.
Microbes Infect.
2002;
4 (13)
1309-1316
-
15
Tam J S.
Influenza A (H5N1) in Hong Kong: an overview.
Vaccine.
2002;
20 Suppl 2
77-81
-
16
Jefferson T O, Demicheli V, Deeks J J. et al .
Amantadine and rimantadine for preventing and treating influenza A in adults.
Cochrane Database Syst Rev.
2002;
(3)
CD001169
-
17
Jefferson T, Demicheli V, Deeks J. et al .
Neuraminidase inhibitors for preventing and treating influenza in healthy adults.
Cochrane Database Syst Rev.
2000;
(2)
CD001265
-
18
Boivin G, Goyette N.
Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors.
Antiviral Res.
2002;
54 (3)
143-147
-
19
Sintchenko V, Gilbert G L, Coiera E. et al .
Treat or test first? Decision analysis of empirical antiviral treatment of influenza virus infection versus treatment based on rapid test results.
J Clin Virol.
2002;
25 (1)
15-21
-
20
Oxford J S, Bossuyt S, Balasingam S. et al .
Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors 696.
Clin Microbiol Infect.
2003;
9 (1)
1-14
-
21
Schaberg T.
Pneumokokken-Schutzimpfung.
Pneumologie.
2001;
55 (12)
543-545
-
22
Hedlund J U, Kalin M E, Ortqvist A B. et al .
Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia.
Arch Intern Med.
1994;
154 (17)
1961-1965
-
23
Cornu C, Yzebe D, Leophonte P. et al .
Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials.
Vaccine.
2001;
19 (32)
4780-4790
-
24
Nichol K L, Baken L, Wuorenma J. et al .
The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease.
Arch Intern Med.
1999;
159 (20)
2437-2442
-
25
Medical Research Council .
Value of chemoprophylaxis and chemotherapy in early chronic bronchitis. A report to the Medical Research Council by their working party on trials of chemotherapy in early chronic bronchitis.
Br Med J.
1966;
5499
1317-1322
-
26
Johnston R N, McNeill R S, Smith D H. et al .
Five-year winter chemoprophylaxis for chronic bronchitis.
Br Med J.
1969;
4 (678)
265-269
-
27
Mars G, Santarato R, Necchi D, Silva A.
Prolonged minimal dose administration of sulphamethopyrazine in the treatment and prophylaxis of infectious diseases in the old.
Panminerva Med.
1997;
9
607-610
-
28
Black P, Staykova T, Chacko E. et al .
Prophylactic antibiotic therapy for chronic bronchitis 112.
Cochrane Database Syst Rev.
2003;
(1)
CD004105
-
29
Ramsey B, Pepe M S, Quan J M. et al .
Intermittent administration of inhaled tobramycin in patients with cystic fibrosis.
N Engl J Med.
1999;
340
23-30
-
30
The COPD Guidelines Group of the Standards of Care Committee of the BTS .
BTS guidelines for the management of chronic obstructive pulmonary disease.
Thorax.
1997;
52
1-28
-
31
Bradley J, Moran F, Greenstone M.
Physical training for bronchiectasis.
Cochrane Database Syst Rev.
2002;
(3)
CD002166
-
32
Varekojis S M, Douce F H, Flucke R L. et al .
A comparison of the therapeutic effectiveness of and preference for postural drainage and percussion, intrapulmonary percussive ventilation, and high-frequency chest wall compression in hospitalized cystic fibrosis patients.
Respir Care.
2003;
48 (1)
24-28
-
33
Jones A, Rowe B H.
Bronchopulmonary hygiene physical therapy in bronchiectasis and chronic obstructive pulmonary disease: a systematic review.
Heart Lung.
2000;
29 (2)
125-135
-
34
Poole P J, Black P N.
Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
Cochrane Database Syst Rev.
2003;
(2)
CD001287
-
35
Melchart D, Linde K, Fischer P. et al .
Echinacea for preventing and treating the common cold.
Cochrane Database Syst Rev.
2000;
(2)
CD000530
-
36
Belongia E A, Berg R, Liu K.
A randomized trial of zinc nasal spray for the treatment of upper respiratory illness in adults.
Am J Med.
2001;
111 (2)
103-108
-
37
Vickers A J, Smith C.
Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes.
Cochrane Database Syst Rev.
2000;
(2)
CD001957
-
38
Marshall I.
Zinc for the common cold.
Cochrane Database Syst Rev.
2000;
(2)
CD001364
-
39
Jackson J L, Lesho E, Peterson C.
Zinc and the common cold: a meta-analysis revisited.
J Nutr.
2000;
130 (5S Suppl)
1512-1515
-
40
Foxwell A R, Cripps A W.
Haemophilus influenzae oral vaccination against acute bronchitis.
Cochrane Database Syst Rev.
2003;
(2)
CD001958
-
41
Steurer-Stey C, Bachmann L M, Steurer J. et al .
Oral purified bacterial extracts in chronic bronchitis and COPD: a systematic review.
Chest.
2004;
126
1645-1655
Professor Dr. Tom Schaberg, FCCP
Zentrum für Pneumologie · Diakoniekrankenhaus Rotenburg
Verdener Str. 200
27356 Rotenburg
eMail: schaberg@diako-online.de
